FDA Inspection
Avara Pharmaceutical Technologies, Inc.Avara Pharmaceutical Technologies, Inc. – FDA Inspection, Oct 31, 2022
Record Details
This FDA Inspection record concerns Avara Pharmaceutical Technologies, Inc., with an inspection on October 31, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- October 31, 2022
- Product Type
- Drugs
View Company Profile
ID · a61728e1-15e0-451b-9b67-3ea6b39916a8
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1192124
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Avara Pharmaceutical Technologies, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| June 2, 2026 | Not classified | Dallas District Office | |
| September 26, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 30, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 27, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Avara Pharmaceutical Technologies, Inc.
- FDA Inspection 1322324 - 2026-06-02
- FDA Inspection 1066751 - 2018-09-26
- FDA Inspection 773884 - 2012-03-30
- FDA Inspection 683863 - 2010-09-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.